메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한피부과학회 Annals of Dermatology Annals of Dermatology 제26권 제2호
발행연도
2014.1
수록면
195 - 202 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: In the majority of melanomas, the RAS/RAF/MEK/ERK signaling pathway is constitutively activated, dueto oncogenic mutations in the BRAF and NRAS genes. TheBRAF mutation has been mainly described in Caucasianmelanomas. However, there is a lack of study evaluating thestatus, and the clinical significance, of BRAF mutation in theAsian population. Objective: This study was aimed to determinethe frequency of BRAF mutation, and to evaluate thecorrelation of BRAF status with clinicopathologic featuresand outcomes, in Korean primary acral lentiginous melanoma(ALM) patients. Methods: ALM samples (n=36) wereanalyzed for the BRAF V600E mutation, by dual-primingoligonucleotide (DPO) based real-time polymerase chainreaction. The clinicopathologic features and prognosis of thepatients were analyzed with BRAF mutation status. Results:The incidence of BRAF V600E mutation was 19.4% (7/36). The BRAF V600E mutations were not associated withclinicopathologic features, except for the age factor. All ofthe BRAF-mutant patients survived without recurrence ormetastasis, and have a better clinical outcome than BRAFwild-type patients. Conclusion: In Korean primary ALM, alow frequency of BRAF mutation was shown; and BRAFmutation presented with a favorable prognosis. These resultsindicate that other distinctive genetic mechanisms may havemore important roles in the development and progression ofdisease. Further multicenter study with large sample size isfirmly needed, to confirm the results of our preliminarystudy.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0